Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPMATINIB vs CARBETOCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPMATINIB vs CARBETOCIN: Safety Overview

Metric CAPMATINIB CARBETOCIN
Total FAERS Reports 2,301 146
Deaths Reported 583 0
Death Rate 25.3% N/A
Hospitalizations 388 100
Average Patient Age 71.9 yrs 35.0 yrs
% Female Patients 53.9% 100.0%
FDA Approval Date May 6, 2020 N/A
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route ORAL N/A
Marketing Status Prescription N/A